Wordt geladen...
Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes
Mesenchymal stromal/stem cell (MSC) therapy has shown promise in experimental models of idiopathic pulmonary fibrosis (IPF). The aim of this study was to test the therapeutic effects of extracellular vesicles produced by human BM MSCs (MEx) in a bleomycin-induced pulmonary fibrosis model and investi...
Bewaard in:
| Gepubliceerd in: | JCI Insight |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6948760/ https://ncbi.nlm.nih.gov/pubmed/31581150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.128060 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|